HPV Infection and Vaccination: A Question and Answer Guide for School Nurses

Abstract

School nurses frequently interact with school-age children and their parents/guardians regarding vaccinations. As a trusted source of information, the school nurse is in a unique position to share vaccine information with parents/guardians and school-age children that may dispel myths and, consequently, improve vaccination rates. Nevertheless, some parents/guardians are still reluctant to vaccinate their school-age children against Human Papilloma Virus (HPV) for a variety of reasons. Common barriers to HPV vaccination include a lack of understanding of the vaccine’s purpose, concerns regarding the vaccine’s safety, and insufficient recommendation from healthcare workers. However, school nurses have many duties in addition to ensuring vaccine compliance. School nurses may have difficulty remaining up-to-date on evidence-based answers to parents’/guardians’ questions about HPV vaccine. Therefore, the purpose of this article is to provide school nurses with a quick reference question and answer guide to parents’/guardians’ common HPV-related vaccination questions.

Keywords

HPV immunizations infectious diseases parent/family education educational support

Get full access to this article

View all access options for this article.

References

Advisory Committee on Immunization Practices. (2019, August 16). EtR for HPV vaccination of adults 27-45 years old. https://www.cdc.gov/vaccines/acip/recs/grade/HPV-adults-etr.html

Akinlotan

Bolin

J. N.

Helduser

Ojinnaka

Lichorad

McClellan

(2017). Cervical cancer screening barriers and risk factor knowledge among uninsured women. Journal of Community Health, 42(4), 770–778. https://doi.org/10.1007/s10900-017-0316-9

Ambühl

L. M. M.

Baandrup

Dybkær

Blaakær

Uldbjerg

Sørensen

(2016). Human papillomavirus infection as a possible cause of spontaneous abortion and spontaneous preterm delivery. Infectious Diseases in Obstetrics and Gynecology, 2016, Article 3086036. https://doi.org/10.1155/2016/3086036

Aref-Adib

Freeman-Wang

(2016). Cervical cancer prevention and screening: The role of human papillomavirus testing. The Obstetrician and Gynaecologist, 18(4), 251–263. https://doi.org/10.1111/tog.12279

Armstrong

Spivey

Doran

(2021). Contemporary engagement strategies for nurse leaders. Nurse Leader, 19(4), 360–365. https://doi.org/10.1016/j.mnl.2021.03.011

Baiden

Panisch

L. S.

Kim

Y. J.

LaBrenz

C. A.

Kim

Onyeaka

H. K.

(2021). Association between first sexual intercourse and sexual violence victimization, symptoms of depression, and suicidal behaviors among adolescents in the United States: Findings from 2017 and 2019 National Youth Risk Behavior Survey. International Journal of Environmental Research and Public Health, 18, Article 7922. https://doi.org/10.3390/ijerph18157922

Bergren

M. D.

(2017). School nursing and population health: Past, present and future. Online Journal of Issues in Nursing, 22(3), 1. https://doi.org/10.3912/OJIN.VOL22NO03MAN03

Boeri

Capogrosso

Ventimiglia

Pederzoli

Cazzaniga

Chierigo

Pozzi

Clementi

Viganò

Montanari

Montorsi

Salonia

(2019). High-risk human papillomavirus in semen is associated with poor sperm progressive motility and a high sperm DNA fragmentation index in infertile men. Human Reproduction, 34(2), 209–217. https://doi.org/10.1093/humrep/dey348

Bozigar

Faith

T. D.

White

A. A.

Drayton

K. D.

Fabick

Cartmell

K. B.

(2020). A cross-sectional survey to evaluate potential for partnering with school nurses to promote human papillomavirus vaccination. Preventing Chronic Disease, 17, Article 190451. https://doi.org/10.5888/pcd17.190451

10.

Brand

(2016, May 1). When disaster strikes: Nurse leadership, nursing care, and teamwork save lives. Robert Wood Johnson Foundation. https://www.rwjf.org/en/library/research/2016/05/when-disaster-strikes.html

11.

Centers for Disease Control and Prevention. (2017, January 18). Partners and programs in the spotlight. https://www.cdc.gov/hpv/partners/spotlights/nasn.html

12.

Centers for Disease Control and Prevention. (2018). Cancers associated with human papillomavirus, United States—2011-2015 (United States Cancer Statistics Data Brief, No. 4). https://www.cdc.gov/cancer/hpv/pdf/USCS-DataBrief-No4-August2018-508.pdf

13.

Centers for Disease Control and Prevention. (2021a, December 13). HPV-associated cancer statistics. https://www.cdc.gov/cancer/hpv/statistics/

14.

Centers for Disease Control and Prevention. (2021b, July 23). HPV vaccine. https://www.cdc.gov/hpv/parents/vaccine-for-hpv.html

15.

Centers for Disease Control and Prevention. (2021c, November 8). Key statistics from the National Survey of Family Growth—N listing. https://www.cdc.gov/nchs/nsfg/key_statistics/n-keystat.htm

16.

Centers for Disease Control and Prevention. (2021d, November 10). Reasons to get HPV vaccine. https://www.cdc.gov/hpv/parents/vaccine/six-reasons.html

17.

Centers for Disease Control and Prevention. (2022a, February 28). Cancers caused by HPV. https://www.cdc.gov/hpv/parents/cancer.html

18.

Centers for Disease Control and Prevention. (2022b, February 17). Childhood and adolescent immunization schedules. https://www.cdc.gov/vaccines/schedules/hcp/imz/child-adolescent.html#note-hpv

19.

Centers for Disease Control and Prevention. (2022c, April 12). Genital HPV infection—Basic fact sheet. https://www.cdc.gov/std/hpv/stdfact-hpv.htm

20.

Cotton

(2018). HPV: Immunising boys and parental acceptance. British Journal of School Nursing, 13(5), 249–252. https://doi.org/10.12968/bjsn.2018.13.5.249

21.

DeLong

(2018). A lowered probability of pregnancy in females in the USA aged 25-29 who received a human papillomavirus vaccine injection. Journal of Toxicology and Environmental Health Part A, 81(14), 661–674. https://doi.org/10.1080/15287394.2018.1477640

22.

Demir

Ince

Yilmaz

Decleer

Osmanagaoglu

(2020). The effect of human papilloma virus vaccination on embryo yield and clinical in vitro fertilisation outcomes: A matched retrospective cohort study. Journal of Obstetrics and Gynaecology, 41(3), 421–427. https://doi.org/10.1080/01443615.2020.1739008

23.

Erickson

(2014). How closely does the CDC monitor HPV vaccine safety? SanVax. https://sanevax.org/closely-cdc-monitor-hpv-vaccine-safety/

24.

Faber

M. T.

Dunn-Henriksen

A. K.

Dehlendorff

Tatla

M. K.

Munk

Kjaer

S. K.

(2019). Adverse pregnancy outcomes and infant mortality after quadrivalent HPV vaccination during pregnancy. Vaccine, 37(2), 265–271. https://doi.org/10.1016.j.vaccine.2018.11.030

25.

Galbraith

K. V.

Lechuga

Jenerette

C. M.

Moore

L. A. D.

Palmer

M. H.

Hamilton

J. B.

(2016). Parental acceptance and uptake of the HPV vaccine among African-Americans and Latinos in the United States: A literature review. Social Science & Medicine (1982), 159, 116–126. https://doi.org/10.1016/j.socscimed.2016.04.028

26.

Garland

S. M.

Steben

Sings

H. L.

James

Railkar

Barr

Haupt

R. M.

Joura

E. A.

(2009). Natural history of genital warts: Analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. The Journal of Infectious Diseases, 199(6), 805–814. https://doi.org/10.1086/597071

27.

Garolla

De Toni

Bottacin

Valente

De Rocco Ponce

Di Nisio

Foresta

(2018). Human papillomavirus prophylactic vaccination improves reproductive outcome in infertile patients with HPV semen infection: A retrospective study. Scientific Reports, 8(1), Article 912. https://doi.org/10.1038/s41598-018-19369-z

28.

Goleman

M. J.

Dolce

Morack

(2018). Quality improvement initiative to improve human papillomavirus vaccine initiative at 9 years of age. Academic Pediatrics, 18(7), 769–775. https://doi.org/10.1016/j.acap.2018.05.005

29.

Gurrentz

Mayol-Garcia

(2021, April 22). Marriage, divorce, widowhood remain prevalent among older populations. https://www.census.gov/library/stories/2021/04/love-and-loss-among-older-adults.html

30.

Habakus

L. K.

Holland

Rosenberg

K. M.

(2012). Vaccine epidemic: How corporate greed, biased science, and coercive government threaten our human rights, our health, and our children. Skyhorse Publishing.

31.

Harder

Wichmann

Klug

S. J.

van der Sande

M. A. B.

Wiese-Posselt

(2018). Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: A systematic review. BMC Medicine, 16(1), 1–15. https://doi.org/10.1186/s12916-018-1098-3

32.

Holland

Rosenberg

K. M.

Iorio

(2018). The HPV vaccine on trial: Seeking justice for a generation betrayed. Skyhorse Publishing.

33.

Huang

Wang

Yuan

NAdarzynski

Qian

H. Z.

Meng

Wang

Zhou

Luo

Wang

Cai

Zou

(2021). Using protection motivation theory to explain the intention to initiate human papillomavirus vaccination among men who have sex with men in China. Tumour Virus Research, 12, 200222. https://doi.org/10.1016/j.tvr.2021.200222

34.

Hviid

Thiesson

E. M.

(2021). Association between human papilloma vaccination and primary ovarian insufficiency in a nationwide cohort. JAMA Network Open, 4(8), e2120391. https://doi.org/10.1001/jamanetworkopen.2021.20391

35.

Joura

E. A.

Giuliano

A. R.

Iversen

O.-E.

Bouchard

Mao

Mehlsen

Moreira

E. D.

Ngan

Jr. Petersen

L. K.

Lazcano-Ponce

Pitisuttithum

Restrepo

J. A.

Stuart

Woelber

Yang

Y. C.

Cuzick

Garland

S. M.

Huh

Kjaer

S. K.

. . . Luxembourg

(2015). A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. The New England Journal of Medicine, 372(8), 711–723. https://doi.org/10.1056/NEJMoa1405044

36.

Kaul

T. Q. N.

Hsu

Schmeler

K. M.

Montealegre

J. R.

Rodriguez

A. M.

(2019). School-based human papillomavirus vaccination program for increasing vaccine uptake in an underserved area in Texas. Papillomavirus Research, 8, Article 100189. https://doi.org/10.1016/j.pvr.2019.100189

37.

Khalid

M. B.

Ting

Pai

Russo

J. L.

Bakst

Chai

R. L.

Teng

M. S.

Genden

E. M.

Miles

B. A.

(2018). Initial presentation of human papillomavirus-related head and neck cancer: A retrospective review. Laryngoscope, 129(4), 877–882. https://doi.org/10.1002/lary.27296

38.

Lacey

C. J. N.

Lowndes

C. M.

Shah

K. V.

(2006). Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine, 24(Suppl. 3), 35–41. https://doi.org/10.1016/j.vaccine.2006.06.015

39.

LaVigne

(2015, October 7). HPV vaccines raise international red flags. https://thevaccinereaction.org/2015/10/hpv-vaccines-raise-international-red-flags/#_edn11

40.

Lee

B. H.

O’Sullivan

L. F.

(2019). Walk the line: How successful are efforts to maintain monogamy in intimate relationships? Archives of Sexual Behavior, 48(6), 1735–1748. https://doi.org/10.1007/s10508-018-1376

41.

Lenzer

(2011, November 14). Should boys be given the HPV vaccine? The science is weaker than the marketing. https://www.discovermagazine.com/health/should-boys-be-given-the-hpv-vaccine-the-science-is-weaker-than-the-marketing#.WzaYXaknaqA

42.

Leslie

S. W.

Sajjad

Kumar

(2022). Genital warts. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK441884/

43.

Lindberg

L. D.

Maddow-Zimet

Marcell

A. V.

(2019). Prevalence of sexual initiation before age 13 years among male adolescents and young adults in the United States. JAMA Pediatrics, 173(6), 553–560. https://doi.org/10.1001/jamapediatrics.2019.0458

44.

Lindsay

A. C.

Delgado

Valdez

M. J.

Restrepo

Guzman

Y. M.

(2022). “I don’t think he needs the HPV vaccine cause boys can’t have cervical cancer”: A qualitative study of Latina mothers’ (mis) understandings about human papillomavirus transmission, associated cancers, and the vaccine. Journal of Cancer Education, 37(2), 370–378. https://doi.org/10.1007/s13187-020-01824-z

45.

Little

D. T.

Ward

H. R. G.

(2012). Premature ovarian failure 3 years after menarche in a 16-year-old girl following human papillomavirus vaccination. BMJ Case Report, 2012, bcr2012006879. https://doi.org/10.1136/bcr-2012-006879

46.

Lukacs

Mate

Farkas

Miko

Tenk

Hegyi

Nemeth

Czumbel

L. M.

Wuttapon

Kiss

Gyongyi

Varga

Rumbus

Szabo

(2020). The quadrivalent HPV vaccine is protective against genital warts: A meta-analysis. BMC Public Health, 20(691), 1–16. https://doi.org/10.1186/s12889-020-08753-y

47.

Luthy

K. E.

Burningham

Eden

L. M.

Macintosh

J. L. B.

Beckstrand

R. L.

(2015). Addressing parental vaccination questions in the school setting: An integrative literature review. Journal of School Nursing, 32(1), 47–57. https://doi.org/10.1177/1059840515606501

48.

Lyu

Feng

Zhao

Wei

Chen

Yang

Yao

Zhang

Shen

Hang

Dai

(2017). Human papillomavirus in semen and the risk for male infertility: A systematic review and meta-analysis. BMC Infectious Diseases, 17(1), Article 714. https://doi.org/10.1186/s12879-017-2812-z

49.

Magnusson

B. M.

Crandall

Evans

(2019). Early sexual debut and risky sex in young adults: The role of low self-control. BMC Public Health, 19(1), Article 1483. https://doi.org/10.1186/s12889-019-7734-9

50.

Mansfield

L. N.

Vance

Nikpour

J. A.

Gonzalez-Guarda

R. M.

(2021). A systematic review of human papillomavirus vaccination among US adolescents. Research in Nursing & Health, 44(3), 473–489. https://doi.org/10.1002/nur.22135

51.

McCullough

J. M.

Sunenshine

Rusinak

Mead

England

(2020). Association of presence of a school nurse with increased sixth-grade immunization rates in low-income Arizona schools in 2014–2015. Journal of School Nursing, 36(5), 360–368. https://doi.org/10.1177/1059840518824639

52.

McInerney

K. A.

Hatch

E. E.

Wesselink

A. K.

Mikkelsen

E. M.

Rothman

K. J.

Perkins

R. B.

Wise

L. A.

(2017). The effect of vaccination against human papillomavirus on fecundability. Paediatric and Perinatal Epidemiology, 31(6), 531–536. https://doi.org/10.1111/ppe.12408

53.

Meites

Gee

Unger

Markowitz

(2020, August). Human papillomavirus. https://www.cdc.gov/vaccines/pubs/pinkbook/downloads/hpv.pdf

54.

Meites

Kempe

Markowitz

L. E.

(2016). Use of a 2-dose schedule for human papillomavirus vaccination—Updated recommendations of the Advisory Committee on Immunization Practices. Morbidity and Mortality Weekly Report, 65(49), 1405–1408. https://doi.org/10.15585/mmwr.mm6549a5

55.

Meites

Szilagyi

P. G.

Chesson

H. W.

Unger

E. R.

Romero

J. R.

Markowitz

L. E.

(2019). Human papillomavirus (HPV): HPV vaccine schedule and dosing. Morbidity and Mortality Weekly Report, 68(32), 698–702.

56.

National Association of School Nurses. (2018). Healthy communities—The role of the school nurse [Position Statement].

57.

National Association of School Nurses. (2020). Strategic plan—2020-2023. https://www.nasn.org/about-nasn/about

58.

National Association of School Nurses. (2021, June). Code of ethics. https://www.nasn.org/nasn-resources/resources-by-topic/codeofethics

59.

National Cancer Institute. (2021a, October 22). Despite proven safety of HPV vaccines, more parents have concerns. https://www.cancer.gov/news-events/cancer-currents-blog/2021/hpv-vaccine-parents-safety-concerns

60.

National Cancer Institute. (2021b, May 25). Human papillomavirus (HPV) vaccines. https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet

61.

National Library of Medicine. (2019). RETRACTED ARTICLE: [A lowered probability of pregnancy in females in the USA aged 25-29 who received a human papillomavirus vaccine injection]. Journal of Toxicology and Environmental Health, Part A, 85(11), i. https://doi.org/10.1080/15287394.2019.1669991

62.

National Sexual Violence Resource Center. (2018). Teenagers & sexual violence. https://www.nsvrc.org/sites/default/files/publications/2019-02/Teenagers_508.pdf

63.

Nguyen

K. H.

Santibanez

T. A.

Stokley

Lindley

M. C.

Fisher

Kim

Greby

Srivastav

Singleton

(2021). Parental vaccine hesitancy and its association with adolescent HPV vaccination. Vaccine, 39(17), 2416–2423. https://doi.org/10.1016/j.vaccine.2021.03.048

64.

Niyibizi

Mayrand

Audibert

Monnier

Brassard

Laporte

Lacaille

Zahreddine

Bedard

M. J.

Girard

Francoeur

Carceller

A. M.

Lacroix

Fraser

Coutlee

Trottier

H., &

HERITAGE Study Group. (2021). Association between human papillomavirus infection among pregnant women and preterm birth. JAMA Network Open, 4(9), Article e2125308. https://doi.org/10.1001/jamanetworkopen.2021.25308

65.

Raines

Fisher

B. L.

(2018, November 14). Mass HPV vaccination plan for the U.S. https://thevaccinereaction.org/2018/11/mass-hpv-vaccination-plan-for-the-u-s/

66.

Rendle

K. A.

Leskinen

E. A.

(2017). Timing is everything: Exploring parental decisions to delay HPV vaccination. Qualitative Health Research, 27(9), 1380–1390. https://doi.org/10.1177/1049732316664499

67.

Reynolds

Profile

T. F.

(2020). Divorce rate in the US: Geographic variation, 2019. https://www.bgsu.edu/ncfmr/resources/data/family-profiles/reynolds-divorce-rate-geographic-variation-2019-fp-20-25.html

68.

Rodríguez-Álvarez

M. I.

Gómez-Urquiza

J. L.

Ahmed

H. E.

Albendín-García

Gómez-Salgado

(2018). Prevalence and risk factors of human papillomavirus in male patients: A systematic review and meta-analysis. International Journal of Environmental Research and Public Health, 15(10), Article 2210. https://doi.org/10.3390/ijerph15102210

69.

Rosen

B. L.

DiClemente

Shepard

A. L.

Wilson

K. L.

Fehr

S. K.

(2017). Factors associated with school nurses’ HPV vaccine attitudes for school-aged youth. Psychology, Health & Medicine, 22(5), 535–545. https://doi.org/10.1080/13548506.2016.1173710

70.

Safaeian

Sampson

J. N.

Pan

Poraras

Kemp

T. J.

Herrero

Quint

van Doorn

L. J.

Schussler

Lowy

D. R.

Schiller

Schiffman

M. T.

Rodriguez

A. C.

Gil

M. H.

Hildesheim

Gonzalez

Pinto

L. A.

Kreimer

A. R.

(2018). Durability of protection afforded by fewer doses of the HPV16/18 vaccine: The CVT trial. Journal of the National Cancer Institute, 110(2), 205–212. https://doi.org/10.1093/jnci/djx158

71.

Saslow

Andrews

K. S.

Manassaram-Baptiste

Smith

R. A.

Fontham

E. T. H.

, & The American Cancer Society Guideline Development Group. (2020). Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideline adaptation. Cancer Journal for Clinicians, 70(4), 274–280. https://doi.org/10.3322/caac.21616

72.

Schmeler

K. M.

Sturgis

E. M.

(2016). Expanding the benefits of HPV vaccination to boys and men. The Lancet, 387(10030), 1798–1799. https://doi.org/10.1016/S0140-6736(16)30314-2

73.

Schmuhl

N. B.

Mooney

K. E.

Zhang

Cooney

L. G.

Conway

J. H.

LoConte

N. K.

(2020). No association between HPV vaccination and infertility in U.S. females 18-33 years old. Vaccine, 38(24), 4038–4043. https://doi.org/10.1016/j.vaccine.2020.03.035

74.

Schweizer

(2020). Age variation in the remarriage rate, 1990 & 2018. https://www.bgsu.edu/ncfmr/resources/data/family-profiles/schweizer-age-variation-remarriage-rate-1990-2018-fp-20-13.html

75.

Sears

(2011). The vaccine book: Making the right decision for your child (2nd ed.). Little, Brown and Company.

76.

Simple Online Healthcare Limited. (2022). Sexual exposure and STI risk calculator. https://www.drfelix.co.uk/sexual-exposure-sti-risk-calculator/

77.

Souho

Benlemlih

Bennani

(2015). Human papillomavirus infection and fertility alteration: A systematic review. PLOS ONE, 10(5), Article e0126936. https://doi.org/10.1371/journal.pone.0126936

78.

Stout

M. E.

Christy

S. M.

Winger

J. G.

Vadaparampil

S. T.

Mosher

C. E.

(2020). Self-efficacy and HPV vaccine attitudes mediate the relationship between social norms and intentions to receive the HPV vaccine among college students. Journal of Community Health, 45(6), 1187–1195. https://doi.org/10.1007/s10900-020-00837-5

79.

Stout

P. Z.

Martins

D. C.

(2019). Missed opportunities to immunize young adult males with the HPV vaccine to reduce oropharyngeal cancer. The Nurse Practitioner, 44(7), 10–13. https://doi.org/10.1097/01.NPR.0000559850.06744.e0

80.

Subasinghe

A. K.

Wark

J. D.

Phillips

Cornall

Brotherton

J. M. L.

Garland

S. M.

(2020). Quadrivalent human papillomavirus vaccination successfully reduces the prevalence of vaccine-targeted genotypes in a young, vaccine-eligible-age sample of Australian females. Sexual Health, 17(6), 510–516. https://doi.org/10.1071/SH20033

81.

Swift

Heale

Twycross

(2020). What are sensitivity and specificity? Evidence-Based Nursing, 23(1), 2–4. https://doi.org/10.1136/ebnurs-2019-103225

82.

Szilagyi

P. G.

Schaffer

Rand

C. M.

Goldstein

N. P.

Hightower

A. D.

Younge

Albertin

C. S.

DiBitetto

Yoo

B. K.

Humiston

S. G.

(2019). School-located influenza vaccination: Do vaccine clinics at school raise vaccination rates? Journal of School Health, 89(12), 1004–1012. https://doi.org/10.1111/josh.12840

83.

Thompson

E. L.

Vamos

C. A.

Piepenbrink

Kadono

Vazquez-Otero

Matthew

Daley

E. M.

(2019). Human papillomavirus risk perceptions and relationship status: A barrier to HPV vaccination? Journal of Behavioral Medicine, 42(2019), 991–997. https://doi.org/10.1007/s10865-019-00025-4

84.

U.S. Food and Drug Administration. (2018). FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old. https://www.fda.gov/news-events/press-announcements/fda-approves-expanded-use-gardasil-9-include-individuals-27-through-45-years-old

85.

The Vaccine Reaction. (2020, July 19). American Cancer Society tells doctors to give nine-year-old children HPV vaccine. https://thevaccinereaction.org/2020/07/american-cancer-society-tells-doctors-to-give-nine-year-old-children-hpv-vaccine/#_edn3

86.

Vahedpoor

Behrashi

Khamehchian

Abedzadeh-Kalahroudi

Moravveji

Mohmadi-Kartalayi

(2019). Comparison of the diagnostic value of the visual inspection with acetic acid (VIA) and Pap smear in cervical cancer screening. Taiwanese Journal of Obstetrics and Gynecology, 58(3), 345–348. https://doi.org/10.1016/j.tjog.2019.03.010

87.

Vasudevan

Ostermann

Wang

Harrison

S. E.

Yelverton

McDonald

J. A.

Fish

L. J.

Williams

Walter

E. B.

(2021). Predictors of HPV vaccination in the southern US: A survey of caregivers from 13 states. Vaccine, 39(51), 7485–7493. https://doi.org/10.1016/j.vaccine.2021.10.036

88.

Vercruysse

Chigurupati

N. L.

Fung

Apte

Pierre-Joseph

Perkins

R. B.

(2016). Parents’ and providers’ attitudes toward school-located provision and school-entry requirements for HPV vaccines. Human Vaccines and Immunotherapeutics, 12(6), 1606–1614. https://doi.org/10.1080/21645515.2016.1140289

89.

Waters

A. V.

Merrell

L. K.

Thompson

E. L.

(2021). Monogamy as a barrier to human papillomavirus catch-up vaccination. Journal of Women’s Health, 30(5), 705–712. https://doi.org/10.1089/jwh.2020.8724

90.

Woestenberg

P. J.

van Benthem

B. H. B.

Bogaards

J. A.

King

A. J.

van der Klis

F. R. M.

Pasmans

Leussink

van der Sande

M. A. B.

Hoebe

C. J. P. A

., Medical Microbiological Laboratories, & The Public Health Services. (2020). HPV infections among young MSM visiting sexual health centers in the Netherlands: Opportunities for targeted HPV vaccination. Vaccine, 38(17), 3321–3329. https://doi.org/10.1016/j.vaccine.2020.03.002

91.

Wong

L. P.

Edib

Alias

Mohamad Shakir

S. M.

Raja Muhammad Yusoff

R. N. A.

Sam

Zimet

G. D.

(2017). A study of physicians’ experiences with recommending HPV vaccines to adolescent boys. Journal of Obstetrics and Gynaecology, 37(7), 937–943. https://doi.org/10.1080/01443515.2017.1317239

92.

World Health Organization. (2020a, February 22). Human papillomavirus (HPV) and cervical cancer. https://www.who.int/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer

93.

World Health Organization. (2020b). Human papilloma virus vaccines and infertility. Weekly Epidemiological Record, 95(4), 25–36.

94.

Zhang

Fakhry

D’Souza

(2021). Projected association of human papillomavirus vaccination with oropharynx cancer incidence in the US, 2020-2045. JAMA Oncology, 7(10), Article e212907. https://doi.org/10.1001/jamaoncol.2021.2907